Randomized, Multicenter, Vehicle-Controlled, Double-Masked Phase 3 Study to Evaluate the Efficacy and Safety of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF])...

Project: Research project

Status	Active
Effective start/end date	3/2/26 → 3/31/36

Project Details